Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
Invesco Nasdaq Biotechnology ETF
ETF
IBBQ
Payout Change
Pending
Price as of:
$21.52
+0.12
+0.56%
primary theme
N/A
IBBQ (ETF)
Invesco Nasdaq Biotechnology ETF
Payout Change
Pending
Price as of:
$21.52
+0.12
+0.56%
primary theme
N/A
IBBQ (ETF)
Invesco Nasdaq Biotechnology ETF
Payout Change
Pending
Price as of:
$21.52
+0.12
+0.56%
primary theme
N/A
Name
As of 12/31/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
Vitals
YTD Return
0.0%
1 yr return
-2.4%
3 Yr Avg Return
-2.3%
5 Yr Avg Return
N/A
Net Assets
$41.1 M
Holdings in Top 10
73.1%
52 WEEK LOW AND HIGH
$21.4
$20.28
$24.66
Expenses
OPERATING FEES
Expense Ratio 0.19%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover N/A
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 12/31/2024Price
Aum/Mkt Cap
YIELD
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
Exp Ratio
Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.
Watchlist
IBBQ - Profile
Distributions
- YTD Total Return 0.0%
- 3 Yr Annualized Total Return -2.3%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio N/A
- Dividend Yield 1.2%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameInvesco Nasdaq Biotechnology ETF
-
Fund Family NameINVESCOETF
-
Inception DateJun 11, 2021
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerPeter Hubbard
Fund Description
The Fund generally will invest at least 90% of its total assets in the securities that comprise the Underlying Index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (“Nasdaq” or the “Index Provider”) compiles the Underlying Index, which is a modified market-capitalization weighted index that is designed to measure the performance of securities of companies listed on the Nasdaq Stock Market that are classified under the biotechnology subsector or pharmaceuticals subsector of the Industry Classification Benchmark (“ICB”).
The Underlying Index may include securities of large-, mid- and small-capitalization companies.
The Underlying Index is rebalanced annually in December and reweighted quarterly, effective at market open of the following trading day after the close of trading on the third Friday in March, June, September and December. The Fund is rebalanced and reweighted in accordance with the Underlying Index. Securities in the Underlying Index are weighted by market capitalization. At each quarter, Nasdaq reweights the Underlying Index such that the maximum weight of any constituent does not exceed 8% of the weight of the Underlying Index. Only the five largest securities may exceed a 4% cap; the individual weight of all other remaining constituents may not exceed 4% of the weight of the Underlying Index.
As of October 31, 2024, the Underlying Index was comprised of 213 constituents with market capitalizations ranging from approximately $16.7 million to $220.6 billion.
The Fund employs a “full replication” methodology in seeking to track the Underlying Index, meaning that the Fund generally invests in all of the securities comprising the Underlying Index in proportion to their weightings in the Underlying Index.
The Fund is “non-diversified” and therefore is not required to meet certain diversification requirements under the Investment Company Act of 1940, as amended (the “1940 Act”).
Concentration Policy. The Fund will concentrate its investments (i.e., invest more than 25% of the value of its net assets) in securities of issuers in the biotechnology or pharmaceutical industries that are contained in the Underlying Index. As of August 31, 2024, the Fund had significant exposure to the biotechnology industry. The Fund's portfolio holdings, and the extent to which it concentrates its investments, are likely to change over time.
IBBQ - Performance
Return Ranking - Trailing
| Period | IBBQ Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 0.0% | -25.6% | 23.4% | 96.65% |
| 1 Yr | -2.4% | -30.0% | 21.8% | N/A |
| 3 Yr | -2.3%* | -18.7% | 19.7% | N/A |
| 5 Yr | N/A* | -14.7% | 15.3% | N/A |
| 10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Return Ranking - Calendar
| Period | IBBQ Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2024 | -1.7% | -53.9% | 11.7% | N/A |
| 2023 | 3.8% | -22.3% | 18.5% | N/A |
| 2022 | -11.1% | -4.7% | 41.4% | N/A |
| 2021 | N/A | -10.2% | 13.1% | N/A |
| 2020 | N/A | -5.7% | 26.9% | N/A |
Total Return Ranking - Trailing
| Period | IBBQ Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | 0.0% | -41.2% | 23.4% | 96.09% |
| 1 Yr | -2.4% | -30.0% | 28.3% | N/A |
| 3 Yr | -2.3%* | -18.7% | 19.7% | N/A |
| 5 Yr | N/A* | -14.7% | 15.3% | N/A |
| 10 Yr | N/A* | -6.2% | 15.7% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | IBBQ Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2024 | -0.6% | -53.9% | 11.7% | N/A |
| 2023 | 4.7% | -22.3% | 18.5% | N/A |
| 2022 | -10.4% | -4.7% | 41.4% | N/A |
| 2021 | N/A | -10.2% | 13.1% | N/A |
| 2020 | N/A | -5.7% | 26.9% | N/A |
IBBQ - Holdings
Concentration Analysis
| IBBQ | Category Low | Category High | IBBQ % Rank | |
|---|---|---|---|---|
| Net Assets | 41.1 M | 732 K | 46.2 B | 81.42% |
| Number of Holdings | 219 | 21 | 473 | 2.62% |
| Net Assets in Top 10 | 28.1 M | 2.18 K | 21.6 B | 74.35% |
| Weighting of Top 10 | 73.11% | 12.3% | 80.8% | 17.80% |
Top 10 Holdings
- Invesco Private Prime Fund 19.20%
- Gilead Sciences, Inc. 8.88%
- Regeneron Pharmaceuticals, Inc. 8.73%
- Amgen Inc. 7.89%
- Vertex Pharmaceuticals Inc. 7.87%
- Invesco Private Government Fund 7.48%
- AstraZeneca PLC, ADR 4.06%
- Alnylam Pharmaceuticals, Inc. 3.24%
- Biogen Inc. 2.91%
- Moderna, Inc. 2.85%
Asset Allocation
| Weighting | Return Low | Return High | IBBQ % Rank | |
|---|---|---|---|---|
| Stocks | 99.92% | 85.37% | 106.13% | 1.57% |
| Cash | 26.68% | -0.10% | 9.01% | 100.00% |
| Preferred Stocks | 0.00% | 0.00% | 7.86% | 60.73% |
| Other | 0.00% | -22.99% | 3.38% | 62.30% |
| Convertible Bonds | 0.00% | 0.00% | 0.37% | 60.73% |
| Bonds | 0.00% | 0.00% | 12.39% | 60.21% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | IBBQ % Rank | |
|---|---|---|---|---|
| Utilities | 0.00% | 0.00% | 0.00% | 58.64% |
| Technology | 0.00% | 0.00% | 22.69% | 62.30% |
| Real Estate | 0.00% | 0.00% | 7.13% | 61.78% |
| Industrials | 0.00% | 0.00% | 7.02% | 61.78% |
| Healthcare | 0.00% | 59.26% | 100.00% | 32.46% |
| Financial Services | 0.00% | 0.00% | 1.85% | 72.25% |
| Energy | 0.00% | 0.00% | 0.00% | 58.64% |
| Communication Services | 0.00% | 0.00% | 9.11% | 61.26% |
| Consumer Defense | 0.00% | 0.00% | 25.73% | 62.30% |
| Consumer Cyclical | 0.00% | 0.00% | 14.20% | 60.73% |
| Basic Materials | 0.00% | 0.00% | 14.83% | 71.20% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | IBBQ % Rank | |
|---|---|---|---|---|
| US | 99.92% | 53.67% | 104.41% | 40.31% |
| Non US | 0.00% | 0.00% | 45.40% | 49.74% |
IBBQ - Expenses
Operational Fees
| IBBQ Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.19% | 0.08% | 3.13% | 97.94% |
| Management Fee | 0.19% | 0.00% | 1.25% | 3.28% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
| IBBQ Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 0.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
| IBBQ Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| IBBQ Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | N/A | 0.00% | 238.00% | 9.59% |
IBBQ - Distributions
Dividend Yield Analysis
| IBBQ | Category Low | Category High | IBBQ % Rank | |
|---|---|---|---|---|
| Dividend Yield | 1.15% | 0.00% | 2.44% | 6.12% |
Dividend Distribution Analysis
| IBBQ | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Quarterly | Annually | Quarterly | Annually |
Net Income Ratio Analysis
| IBBQ | Category Low | Category High | IBBQ % Rank | |
|---|---|---|---|---|
| Net Income Ratio | N/A | -2.54% | 1.92% | 11.83% |
Capital Gain Distribution Analysis
| IBBQ | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Dec 23, 2024 | $0.062 | OrdinaryDividend |
| Sep 23, 2024 | $0.089 | OrdinaryDividend |
| Jun 24, 2024 | $0.051 | OrdinaryDividend |
| Mar 18, 2024 | $0.044 | OrdinaryDividend |
| Dec 18, 2023 | $0.053 | OrdinaryDividend |
| Sep 18, 2023 | $0.041 | OrdinaryDividend |
| Jun 20, 2023 | $0.045 | OrdinaryDividend |
| Mar 20, 2023 | $0.038 | OrdinaryDividend |
| Dec 19, 2022 | $0.042 | OrdinaryDividend |
| Sep 19, 2022 | $0.038 | OrdinaryDividend |
| Jun 21, 2022 | $0.043 | OrdinaryDividend |
| Mar 21, 2022 | $0.038 | OrdinaryDividend |
| Dec 20, 2021 | $0.105 | OrdinaryDividend |
| Sep 20, 2021 | $0.043 | OrdinaryDividend |
IBBQ - Fund Manager Analysis
Managers
Peter Hubbard
Start Date
Tenure
Tenure Rank
Jun 09, 2021
0.98
1.0%
Peter Hubbard, Vice President and Director of Portfolio Management of the Invesco PowerShares Capital Management LLC. Mr. Hubbard has been a Portfolio Manager of the Adviser since June 2007 and has been associated with the Adviser since 2005. Prior to joining the Invesco PowerShares Capital Management LLC, Hubbard was a research analyst and trader for Ritchie Capital from September 2003 to May 2005.
Tony Seisser
Start Date
Tenure
Tenure Rank
Jun 09, 2021
0.98
1.0%
Tony Seisser is a Vice President and Portfolio Manager of Invesco PowerShares Capital Management LLC since December 2013. Prior to joining the Adviser, he was employed by Guggenheim Funds Distributors, Inc. where he was a trader from 2010 to 2013. Prior to that, Mr. Seisser was a compliance investigator at the Chicago Board of Options Exchange and Chicago Futures Exchange from 2008 to 2010.
Pratik Doshi
Start Date
Tenure
Tenure Rank
Jun 09, 2021
0.98
1.0%
Pratik Doshi is a Portfolio Manager of Invesco Capital Management. Mr. Doshi has been a Portfolio Manager of Invesco Capital Management since October 2019 and has been associated with Invesco Capital Management since 2018. Prior to joining Invesco Capital Management, Mr. Doshi was a business student in the MBA program at the University of Chicago from 2016 to 2018. From 2014 to 2016, he served as a Vice President at Bank of America, and from 2007 to 2014 he served as Assistant Vice President at Barclays Capital.
Michael Jeanette
Start Date
Tenure
Tenure Rank
Jun 09, 2021
0.98
1.0%
Michael Jeanette, Senior Portfolio Manager of Invesco Capital Management LLC, has been associated with Invesco Capital Management LLC since 2008. Prior to joining Invesco Capital Management LLC, Mr. Jeanette was a trust advisor and GM of Chicago based Richard Lamb, LLC from 1998 to 2007.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.02 | 24.72 | 7.26 | 2.12 |
